Canada markets closed

SpringWorks Therapeutics, Inc. (SWTX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
46.84+0.15 (+0.32%)
At close: 04:00PM EDT
47.90 +1.06 (+2.26%)
After hours: 07:04PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 3.46B
Enterprise Value 2.99B
Trailing P/E 21.09
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)541.08
Price/Book (mrq)5.52
Enterprise Value/Revenue 548.14
Enterprise Value/EBITDA -8.75

Trading Information

Stock Price History

Beta (5Y Monthly) 0.82
52-Week Change 393.25%
S&P500 52-Week Change 323.57%
52 Week High 353.92
52 Week Low 318.00
50-Day Moving Average 347.44
200-Day Moving Average 334.58

Share Statistics

Avg Vol (3 month) 31.16M
Avg Vol (10 day) 3909.27k
Shares Outstanding 574.06M
Implied Shares Outstanding 674.06M
Float 868.05M
% Held by Insiders 12.24%
% Held by Institutions 1107.50%
Shares Short (Apr 15, 2024) 410.54M
Short Ratio (Apr 15, 2024) 413.07
Short % of Float (Apr 15, 2024) 417.24%
Short % of Shares Outstanding (Apr 15, 2024) 414.24%
Shares Short (prior month Mar 15, 2024) 411.17M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,807.66%

Management Effectiveness

Return on Assets (ttm)-31.62%
Return on Equity (ttm)-54.90%

Income Statement

Revenue (ttm)5.45M
Revenue Per Share (ttm)0.09
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -341.35M
Net Income Avi to Common (ttm)-325.1M
Diluted EPS (ttm)-5.15
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)479.2M
Total Cash Per Share (mrq)6.5
Total Debt (mrq)7.06M
Total Debt/Equity (mrq)1.13%
Current Ratio (mrq)6.41
Book Value Per Share (mrq)8.53

Cash Flow Statement

Operating Cash Flow (ttm)-222.8M
Levered Free Cash Flow (ttm)-113.19M